Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis

Astuti, Y. et al. (2024) Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Nature Cancer, (doi: 10.1038/s43018-024-00731-2) (PMID:38355776) (Early Online Publication)

[img] Text
321542.pdf - Published Version
Available under License Creative Commons Attribution.

21MB

Abstract

Pancreatic ductal adenocarcinoma is a highly metastatic disease and macrophages support liver metastases. Efferocytosis, or engulfment of apoptotic cells by macrophages, is an essential process in tissue homeostasis and wound healing, but its role in metastasis is less well understood. Here, we found that the colonization of the hepatic metastatic site is accompanied by low-grade tissue injury and that efferocytosis-mediated clearance of parenchymal dead cells promotes macrophage reprogramming and liver metastasis. Mechanistically, progranulin expression in macrophages is necessary for efficient efferocytosis by controlling lysosomal acidification via cystic fibrosis transmembrane conductance regulator and the degradation of lysosomal cargo, resulting in LXRα/RXRα-mediated macrophage conversion and upregulation of arginase 1. Pharmacological blockade of efferocytosis or macrophage-specific genetic depletion of progranulin impairs macrophage conversion, improves CD8+ T cell functions, and reduces liver metastasis. Our findings reveal how hard-wired functions of macrophages in tissue repair contribute to liver metastasis and identify potential targets for prevention of pancreatic ductal adenocarcinoma liver metastasis.

Item Type:Articles
Additional Information:These studies were supported by grants from CRUK (A25607, A26978 and A26979), the Medical Research Council (MR/P018920/1) and North West Cancer Research Fund for M.C.S, Wellcome Trust (102521/Z/13/Z) and North West Cancer Research Fund to A.M. and CRUK A17196, A2996 and A25233 to J.P.M.
Keywords:Cancer Research, Oncology
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Nourse, Dr Craig and Morton, Dr Jennifer
Authors: Astuti, Y., Raymant, M., Quaranta, V., Clarke, K., Abudula, M., Smith, O., Bellomo, G., Chandran-Gorner, V., Nourse, C., Halloran, C., Ghaneh, P., Palmer, D., Jones, R. P., Campbell, F., Pollard, J. W., Morton, J. P., Mielgo, A., and Schmid, M. C.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Nature Cancer
Publisher:Nature Research
ISSN:2662-1347
ISSN (Online):2662-1347
Copyright Holders:Copyright: © The Author(s) 2024
First Published:First published in Nature Cancer 2024
Publisher Policy:Reproduced under a Creative Commons licence
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
174328Precision-Panc: a dynamic therapeutic development platform for pancreatic cancerOwen SansomCancer Research UK (CRUK)C7932/A25233SCS - Beatson Institute for Cancer Research